Navigation Links
Walgreens Set to Present at CBI's 3rd Forum on Strategic Distribution Planning for Specialty Products
Date:8/23/2012

WOBURN, Mass., Aug. 23, 2012 /PRNewswire/ -- CBI's 3rd Annual Forum on Strategic Distribution for Specialty Products boasts a speaking faculty that includes Todd Grisco, Vice President, Retail Strategy; Anita Dopkosky, Specialty Account Director at Walgreens; and Keith Loehlein, Senior Principal, Supplier Services, IMS.

This September 20–21, attendees will come together with these experts during the in-conference workshop, Optimize a Multi-Channel Approach http://www.cbinet.com/conference/workshop/23828/pc12131, for a deep dive into the intricacies of a multi-channel strategy by exploring which products are best suited to take this direction along with outcomes to date. Attendees will also delve into payer considerations including reimbursement tendencies, options and trends being seen in alternate sites of care.

This workshop at CBI's 3rd Annual Strategic Distribution Planning for Specialty Products kicks off a strong agenda filled with practical experiences and strategies offering top executives involved in channel strategy a roadmap for ensuring pull-through, use and reimbursement of products within this competitive market segment.

The program is being led by Conference Chairman Mike Castagna, Executive Director, Immunoscience Division at Bristol-Myers Squibb. The Industry Keynote Address is being provided by Michael Howe, Senior Director, Trade Relations, at UCB Inc.

About CBI

CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators.

CONTACT:
Kristina Weljkovic
Phone number: 339-298-2285
Email address: Kristina.weljkovic@cbinet.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE The Center for Business Intelligence
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
3. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
4. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
5. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
6. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
7. InterMune To Present At JMP Securities Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
9. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
10. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
11. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
Breaking Biology News(10 mins):